Fulminant hepatic failure related to omeprazole.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1553942.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Omeprazole is a new hydrogen-potassium adenosine triphosphatase antagonist with indications for severe reflux esophagitis and Zollinger-Ellison syndrome. Side effects involving the liver have consisted of minimal elevations of hepatocellular enzymes with higher dosages. We present what we believe is the first reported case of fulminant hepatic failure related to omeprazole.
Medical subject headings
- Hepatic Encephalopathy
- Omeprazole